Assenagon Asset Management
IRON icon

Assenagon Asset Management’s Disc Medicine IRON Stock Holding History

Assenagon Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.1M Sell
384,158
-162,089
-30% -$11.1M 0.04% 339
2026
Q1 		$34.9M Buy
546,247
+188,411
+53% +$13.1M 0.05% 254
2025
Q4 		$28.4M Buy
357,836
+347,403
+3,330% +$29.4M 0.04% 305
2025
Q3 		$689K Buy
+10,433
New +$621K ﹤0.01% 996
2023
Q4 		– Sell
-74,164
Closed -$3.48M – 1445
2023
Q3 		$3.48M Sell
74,164
-173,236
-70% -$8.67M 0.01% 674
2023
Q2 		$11M Buy
247,400
+185,595
+300% +$6.59M 0.04% 344
2023
Q1 		$1.31M Sell
61,805
-6,621
-10% -$148K ﹤0.01% 967
2022
Q4 		$1.36M Buy
68,426
+65,687
+2,398% +$3.27M ﹤0.01% 955
2022
Q3 		$135K Buy
2,739
+2,216
+424% +$105K ﹤0.01% 1292
2022
Q2 		$27K Buy
+523
New +$23.1K ﹤0.01% 1432

Other funds holding IRON

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EC
Eleva Capital Paris, France $343M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Assenagon Asset Management's IRON Position: Q2 2026 in Review

Assenagon Asset Management reduced its Disc Medicine (IRON) stake by 30% in Q2 2026, selling an estimated $11.1M and leaving 384,158 shares worth $28.1M. The position accounts for 0.04% of the portfolio, ranked #339.

Assenagon Asset Management first reported a position in IRON in Q2 2022 and has held it in 10 quarters since. The position peaked at $34.9M in Q1 2026. 9 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Assenagon Asset Management held 384,158 shares of Disc Medicine worth $28.1M as of Q2 2026.
  • Assenagon Asset Management sold 162,089 Disc Medicine shares in Q2 2026, an estimated $11.1M.
  • Disc Medicine made up 0.04% of Assenagon Asset Management's portfolio in Q2 2026, its #339 holding.
  • Assenagon Asset Management first reported a position in Disc Medicine in Q2 2022 and has held it in 10 quarters since.
  • Assenagon Asset Management's Disc Medicine position peaked at $34.9M in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.